Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
apramycin (1 trial)
buprenorphine (2 trials)
can10 (1 trial)
estradiol (progynon depot) (1 trial)
fentanyl (Innovar) (1 trial)
leo 27847 (1 trial)
murepavadin (1 trial)
Nomegestrol acetate (1 trial)
pertuzumab (perjeta) (1 trial)
safinamide (xadago) (1 trial)
sb010 (2 trials)
Asthma (Phase 1)
Hyperparathyroidism (Phase 1)
Hyperparathyroidism, Secondary (Phase 1)
Liver Diseases (Phase 1)
Neoplasm Metastasis (Phase 1)
Renal Insufficiency (Phase 1)
Trials (12 total)
Trial APIs (11 total)